Tom Saylor is retiring as CEO of Arecor, the position in which he has effectively served for the past 8 years. Although Tom has decided to retire from full time responsibility as CEO he has been asked by the Board to remain as a non-Executive Director of Arecor where he can continue to contribute his network, skills and experience to the ongoing success of the business. Tom will be succeeded by Dr. Sarah Howell who has served as Chief Operating Officer and Vice President for Corporate Development.

Sarah brings very considerable experience from executive roles in the pharmaceutical industry including, most recently, as Vice President for CMC and Technical Development of BTG plc.